Works matching AU Chavira, Renae E

A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor.

Published in:

2017

By:

• Bendell, Johanna C;
• Javle, Milind;
• Bekaii-Saab, Tanios S;
• Finn, Richard S;
• Wainberg, Zev A;
• Laheru, Daniel A;
• Weekes, Colin D;
• Tan, Benjamin R;
• Khan, Gazala N;
• Zalupski, Mark M;
• Infante, Jeffrey R;
• Jones, Suzanne;
• Papadopoulos, Kyriakos P;
• Tolcher, Anthony W;
• Chavira, Renae E;
• Christy-Bittel, Janna L;
• Barrett, Emma;
• Patnaik, Amita

Publication type:

journal article